Agios Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and …

Biotechnology
US, Cambridge [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of AGIO's Analysis
CIK: 1439222 CUSIP: 00847X104 ISIN: US00847X1046 LEI: - UEI: -
Secondary Listings
AGIO has no secondary listings inside our databases.